 Novel molecule targets a newly discovered opioid receptor with atypical properties and holds promise for alternative therapeutic strategies. Researchers at the Department of Infection and Immunity of the Luxembourg Institute of Health LIH developed LIH383, a novel molecule that binds to and blo 